MIRA Pharmaceuticals, Inc. (MIRA) vs InspireMD, Inc. (NSPR)
A side-by-side comparison of MIRA Pharmaceuticals, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MIRA
MIRA Pharmaceuticals, Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 1:26 PM EDT
NSPR
InspireMD, Inc.
$0.56HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT
Total return — MIRA vs NSPR
growth of $100 · dividends reinvested · last 3yMIRA -88.5% (-51.4%/yr)NSPR -87.5% (-50.0%/yr)NSPR compounded faster over this window
MIRA NSPR
MIRA vs NSPR: by the numbers
- •MIRA is the larger company ($30M vs $26M market cap).
- •Both run net losses; MIRA's is the smaller (0.00% vs -355.17% net margin).
Metrics side by side
Valuation
| Metric | MIRA | NSPR |
|---|---|---|
| P/S ratio | N/A | 2.43 |
| P/B ratio | 3.73 | 0.84 |
Profitability
| Metric | MIRA | NSPR |
|---|---|---|
| Gross margin | 0.00% | 29.50% |
| Operating margin | 0.00% | -546.97% |
| Net margin | 0.00% | -355.17% |
| ROE | -116.14% | -122.19% |
| ROIC | -115.18% | -153.04% |
Growth (annualized)
| Metric | MIRA | NSPR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.79% |
| Total return CAGR (5Y) | N/A | -36.91% |
Go deeper
Dig into the metrics
MIRA Pharmaceuticals ROEInspireMD ROEMIRA Pharmaceuticals operating marginInspireMD operating marginMIRA Pharmaceuticals revenue growthInspireMD revenue growthMIRA Pharmaceuticals free cash flowInspireMD free cash flow
MIRA Pharmaceuticals & InspireMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.